← Back to Search

Other

BOR15001L7 Cream for Cold Sores

N/A
Waitlist Available
Research Sponsored by Laboratoire Boreaderme Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

The aim of this study is to determine the safety and efficacy of a topical natural health product in comparison to placebo for the treatment of herpes labialis.

Eligible Conditions
  • Cold Sores

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: BOR15001L7 CreamExperimental Treatment1 Intervention
BOR15001L7 Cream with 5% 15019L0
Group II: Placebo CreamPlacebo Group1 Intervention
Placebo Cream

Find a Location

Who is running the clinical trial?

Laboratoire Boreaderme Inc.Lead Sponsor
1 Previous Clinical Trials
164 Total Patients Enrolled
~4 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top